LifeStance Health (LFST) Gross Profit (2020 - 2024)

LifeStance Health has disclosed Gross Profit across 5 years of filings, most recently posting $100.4 million for Q3 2024.

• In Q3 2024, Gross Profit rose 31.78% year-over-year to $100.4 million; the TTM figure through Sep 2024 stood at $376.3 million (up 33.68% YoY), while the FY2023 annual figure was $302.1 million, up 27.46% from the prior year.
• Gross Profit improved to $100.4 million in Q3 2024, from $97.8 million in the prior quarter.
• Over the last five years, Gross Profit for LFST reached as high as $100.4 million in Q3 2024 and fell as low as $14.2 million in Q2 2020.
• The 5-year median for Gross Profit is $60.3 million (2022), against an average of $63.6 million.
• Annual changes were most pronounced in 2021 — Gross Profit jumped 261.18% — and 2022, when it increased 15.56%.
• A 5-year view of Gross Profit shows it stood at $33.1 million in 2020, then soared by 63.72% to $54.2 million in 2021, then advanced by 15.56% to $62.7 million in 2022, then surged by 32.89% to $83.3 million in 2023, then gained by 20.55% to $100.4 million in 2024.
• According to Business Quant data, Gross Profit over the past three periods registered $100.4 million, $97.8 million, and $94.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.